/
/
/

Arvee Laboratories (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)165.61
Volume (₹)310.00
High (₹)169.40
Upper Circuit198.00
Low (₹)165.00
Lower Circuit132.00
Prev Close165.00
52W High (₹)290.78
Price169.00
52W Low (₹)129.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)181.83 Cr
Div. Yield (%)0.00
PE Ratio44.92
Debt to Equity0.03
Price to Book5.01
Book Value28.37
EPS (TTM)3.67
Face Value10.00
ROE (%)7.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
NAVINFLUORNSE
GODREJINDNSE
DEEPAKNTRNSE
AETHERNSE
ATULNSE
AARTIINDNSE
ARVEENSE
LTP
1W Low
1W High
Market cap (₹)
21415+1015 (4.98%)
19810
21695
1,93,746Cr
1627.6-1.9 (-0.12%)
1612.40
1687.70
1,66,118Cr
2551.9-38 (-1.47%)
2532.20
2648
77,219Cr
4497.1-274.1 (-5.74%)
4478
4850
51,537Cr
8553+35.5 (0.42%)
8275.50
8740
44,624Cr
1169+1.5 (0.13%)
1128.50
1215.90
38,937Cr
1718.8-44.1 (-2.50%)
1705.70
1820
23,559Cr
1619.1-77.7 (-4.58%)
1614.30
1707.80
21,984Cr
6406.5-53 (-0.82%)
6358
6642.50
19,036Cr
494.3-46.05 (-8.52%)
493.10
540.60
18,200Cr
169+0 (0.00%)
162.56
175.11
182Cr

Key Highlights of Arvee Laboratories (India) Ltd Balance Sheet

Arvee Laboratories (India) Ltd balance sheet discloses shareholders' funds of ₹11.02Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹11.02Cr, and the reserves and surplus of the company is ₹20.24Cr.

The company has its non-current liabilities with total liabilities of ₹37.57Cr as of 2025-03-31.

The current liabilities are ₹3.83Cr as of 2025-03-31. At the same time, current assets are ₹19.66Cr as of 2025-03-31.